BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Ningjian Wang, Yuying Wang, Wen Zhang, Yi Chen, Xiaoman Chen, Chiyu Wang, Qing Li, Chi Chen, Boren Jiang, Yingli Lu. C‐peptide is associated with NAFLD inflammatory and fibrotic progression in type 2 diabetesDiabetes/Metabolism Research and Reviews 2020; 36(2) doi: 10.1002/dmrr.3210
2
Asieh Mansour, Mohammad Reza Mohajeri-Tehrani, Majid Samadi, Hadis Gerami, Mostafa Qorbani, Nick Bellissimo, Hossein Poustchi, Azita Hekmatdoost. Risk factors for non-alcoholic fatty liver disease-associated hepatic fibrosis in type 2 diabetes patientsActa Diabetologica 2019; 56(11): 1199 doi: 10.1007/s00592-019-01374-x
3
Mark D. Muthiah, Arun J. Sanyal. Burden of Disease due to Nonalcoholic Fatty Liver DiseaseGastroenterology Clinics of North America 2020; 49(1): 1 doi: 10.1016/j.gtc.2019.09.007
4
Kavita Garg, Scott Brackett, Irl B. Hirsch, Satish K. Garg. NAFLD/NASH and DiabetesDiabetes Technology & Therapeutics 2020; 22(S1): S-174 doi: 10.1089/dia.2020.2513